Sponsored education
| Time | Topic | Presenter |
|---|---|---|
| 7:30am | KEYTRUDA® (pembrolizumab) + chemoradiotherapy: A treatment option for certain patients with high-risk LACC |
Bronwyn Jennings, Gynae Onc CNC |
| 7:45am | Q&A |
Kirsten Stewart (Gynae Onc CNC) |
| 8:30am | Close |